Fatty acid-modified gapmer antisense oligonucleotide and human serum albumin constructs for pharmacokinetic modulation

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Fatty acid-modified gapmer antisense oligonucleotide and human serum albumin constructs for pharmacokinetic modulation. / Hvam, Michael Lykke; Cai, Yunpeng; Dagnæs-Hansen, Frederik; Nielsen, Jesper; Wengel, Jesper; Kjems, Jørgen; Howard, Ken.

In: Molecular Therapy, Vol. 25, No. 7, 05.07.2017, p. 1710-1717.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{d65b1d1575df41d19618e2e2b1a22eb0,
title = "Fatty acid-modified gapmer antisense oligonucleotide and human serum albumin constructs for pharmacokinetic modulation",
author = "Hvam, {Michael Lykke} and Yunpeng Cai and Frederik Dagn{\ae}s-Hansen and Jesper Nielsen and Jesper Wengel and J{\o}rgen Kjems and Ken Howard",
year = "2017",
month = "7",
day = "5",
doi = "10.1016/j.ymthe.2017.05.009",
language = "English",
volume = "25",
pages = "1710--1717",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "7",

}

RIS

TY - JOUR

T1 - Fatty acid-modified gapmer antisense oligonucleotide and human serum albumin constructs for pharmacokinetic modulation

AU - Hvam, Michael Lykke

AU - Cai, Yunpeng

AU - Dagnæs-Hansen, Frederik

AU - Nielsen, Jesper

AU - Wengel, Jesper

AU - Kjems, Jørgen

AU - Howard, Ken

PY - 2017/7/5

Y1 - 2017/7/5

U2 - 10.1016/j.ymthe.2017.05.009

DO - 10.1016/j.ymthe.2017.05.009

M3 - Journal article

VL - 25

SP - 1710

EP - 1717

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 7

ER -